Back to History Current Version

Paternalism and Incentives

Last registered on February 05, 2020

Pre-Trial

Trial Information

General Information

Title
Paternalism and Incentives
RCT ID
AEARCTR-0003801
Initial registration date
January 15, 2020

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
January 17, 2020, 11:13 AM EST

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
February 05, 2020, 4:56 AM EST

Last updated is the most recent time when changes to the trial's registration were published.

Locations

Region

Primary Investigator

Affiliation
New York University Abu Dhabi

Other Primary Investigator(s)

Additional Trial Information

Status
In development
Start date
2020-01-20
End date
2022-07-01
Secondary IDs
Abstract
This study analyzes the effects of incentives on paternalistic interventions on "repugnant transactions."
External Link(s)

Registration Citation

Citation
Stüber, Robert. 2020. "Paternalism and Incentives." AEA RCT Registry. February 05. https://doi.org/10.1257/rct.3801-1.1
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2020-01-20
Intervention End Date
2020-02-29

Primary Outcomes

Primary Outcomes (end points)
- Participants' willingness-to-pay (WTP) for the offer being made or not made.
- Discrete decision whether to approve the offer or not. Participants choose between “Approve,” “Do not approve,” and “Undecided: Let chance decide.”
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
- Participants' belief about the fraction of people accepting the offer for various monetary amounts.
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
The participants in the experiment decide whether to approve a "repugnant transaction."
Experimental Design Details
In the online experiment the participants decide whether to allow the experimenter to offer a third person monetary compensation of varying amounts for registering as a bone marrow donor. The experiment consists of five parts and a post-experimental questionnaire, and follows a 2x2x2 factorial design. The first factor varies between subjects and alters whether the participants i) reveal their willingness-to-pay for the offer being made or not, or ii) make a discrete decision whether to approve the offer or not by choosing between the options “Approve,” “Do not approve,” and “Undecided: Let chance decide.” The second factor varies within subjects and alters whether the participant makes her decision for a low/regular monetary amount (in treatment “LOW”) or a very high monetary amount (in treatment “HIGH”). The order of these two treatments is randomly varied in Part 1 and Part 2 of the experiment. Part 3 repeats HIGH but i) in the treatment condition (“TREATMENT”) the participants are informed that, even if they approve the offer, the offer is made only if the person would be willing to accept the offer for the low monetary amount and ii) in the low probability condition (“LOW_PROB”) the participants are informed that, even if they approve the offer, with a certain probability the offer is not made. Whether a participant participates in TREATMENT or LOW_PROB varies between subjects. Part 4 (“UG”) elicits the behindness aversion of all participants using responder decisions in an ultimatum game. In Part 5 (“BELIEFS”) participants’ beliefs about reservation prices are assessed. Participants are asked to state their beliefs about the fraction of people who are willing to register as a bone marrow donor for various monetary amounts of compensation. Finally, a post-experimental questionnaire (“QUEST”) asks participants whether they consider the offer in HIGH to be coercive, and elicits risk-preferences, a psychological measure of envy, and basic demographics.
Randomization Method
The randomization is done by a computer. The variable "id_in_group" randomizes participants into treatments.
Randomization Unit
The randomization unit is the individual.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
About 1000 clusters.
Sample size: planned number of observations
About 1000 participants.
Sample size (or number of clusters) by treatment arms
Outcome 1: About 375 participants in the treatment group and 375 participants in the control group.
Outcome 2: About 125 participants in the treatment group and 125 participants in the control group.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
IRB

Institutional Review Boards (IRBs)

IRB Name
WZB Research Ethics Committee
IRB Approval Date
2019-01-22
IRB Approval Number
2019/1/59
Analysis Plan

Analysis Plan Documents

Pre-Analysis Plan (Main Study)

MD5: cef6461c688be868b3f353e67101d425

SHA1: cf734be70546ae50f3e46aff06af0befd4d01d74

Uploaded At: February 05, 2020

Pre-Analysis Plan

MD5: 710b33ef323402af549bac975e03379c

SHA1: 3ba5511a053a969949090828442369aebbc01b27

Uploaded At: January 15, 2020

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials